Kylie Luong

4PUBLICATIONS
25CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Neural engineeringInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 08, 2021
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.

Nicolas Jacquelot, Cyril Seillet, Minyu Wang

|May 12, 2021
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.

Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey

|Feb 01, 2020
Author Correction: The neuropeptide VIP confers anticipatory mucosal immunity by regulating ILC3 activity.

Cyril Seillet, Kylie Luong, Julie Tellier

|Dec 25, 2019
The neuropeptide VIP confers anticipatory mucosal immunity by regulating ILC3 activity.

Cyril Seillet, Kylie Luong, Julie Tellier

Pageof 1